Canada Biotechnology & Medical Research

Restart Life Sciences Corp (HEAL)

Track

Track

Restart Life Sciences Corp experienced consistent insider buying activity recently. Director and senior officer Steve Loutskou, alongside board member Khavita Harrycharran, executed multiple purchase transactions. These acquisitions reflect internal confidence without any recorded sales. Such accumulation patterns occurred independently of specific public results financiers disclosures or market performance metrics.
Ticker: HEAL Exchange: CNX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Loutskou, Steve Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
185.37
Quantity 66,948 -32.5%
Value CA$833,511
Loutskou, Steve Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
458.66
Quantity 38,374
Value CA$941,015
Loutskou, Steve Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
204.27
Quantity 48,456 +33.1%
Value CA$3,164,139
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 50,000
Value CA$4,750
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 12,000 +0.5%
Value CA$1,140
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.10
Quantity 10,000 +0.4%
Value CA$1,000
Loutskou, Steve Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.10
Quantity 2,500 +1.7%
Value CA$238
Loutskou, Steve Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.09
Quantity 25,000 +20.6%
Value CA$2,250
Loutskou, Steve Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.10
Quantity 12,500 +11.5%
Value CA$1,250
Loutskou, Steve Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.10
Quantity 20,500 +23.2%
Value CA$2,050
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.09
Quantity 400,000 +19.4%
Value CA$36,000
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.09
Quantity 250,000 +13.8%
Value CA$22,500
Loutskou, Steve Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.10
Quantity 88,500
Value CA$8,850
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.11
Quantity 150,000 +9.0%
Value CA$16,500
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.11
Quantity 50,000
Value CA$5,500
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.11
Quantity 75,000 +4.9%
Value CA$8,250
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.11
Quantity 378,893 +32.7%
Value CA$41,678
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.11
Quantity 200,000 +20.8%
Value CA$22,000
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.11
Quantity 24,911 +2.7%
Value CA$2,740
Harrycharran, Khavita Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.12
Quantity 50,000 +5.6%
Value CA$6,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-29 2026-06-26 B Purchase
Loutskou, Steve

Director of Issuer, Senior Officer of Issuer

Executive Director
66,948 -32.5%
185.37
CA$833,511 		66,948 -32.5% 185.37 CA$833,511
2026-05-21 2026-05-20 B Purchase
Loutskou, Steve

Director of Issuer, Senior Officer of Issuer

Executive Director
38,374
458.66
CA$941,015 		38,374 458.66 CA$941,015
2026-05-20 2026-05-15 B Purchase
Loutskou, Steve

Director of Issuer, Senior Officer of Issuer

Executive Director
48,456 +33.1%
204.27
CA$3,164,139 		48,456 +33.1% 204.27 CA$3,164,139
2026-05-20 2026-05-15 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
50,000
0.10
CA$4,750 		50,000 0.10 CA$4,750
2026-04-30 2026-04-28 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
12,000 +0.5%
0.10
CA$1,140 		12,000 +0.5% 0.10 CA$1,140
2026-04-30 2026-04-28 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
10,000 +0.4%
0.10
CA$1,000 		10,000 +0.4% 0.10 CA$1,000
2026-04-27 2026-04-27 B Purchase
Loutskou, Steve

Director of Issuer, Senior Officer of Issuer

Executive Director
2,500 +1.7%
0.10
CA$238 		2,500 +1.7% 0.10 CA$238
2026-04-21 2026-04-21 B Purchase
Loutskou, Steve

Director of Issuer, Senior Officer of Issuer

Executive Director
25,000 +20.6%
0.09
CA$2,250 		25,000 +20.6% 0.09 CA$2,250
2026-03-25 2026-03-25 B Purchase
Loutskou, Steve

Director of Issuer, Senior Officer of Issuer

Executive Director
12,500 +11.5%
0.10
CA$1,250 		12,500 +11.5% 0.10 CA$1,250
2026-03-20 2026-03-20 B Purchase
Loutskou, Steve

Director of Issuer, Senior Officer of Issuer

Executive Director
20,500 +23.2%
0.10
CA$2,050 		20,500 +23.2% 0.10 CA$2,050
2026-03-23 2026-03-17 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
400,000 +19.4%
0.09
CA$36,000 		400,000 +19.4% 0.09 CA$36,000
2026-03-23 2026-03-16 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
250,000 +13.8%
0.09
CA$22,500 		250,000 +13.8% 0.09 CA$22,500
2026-03-10 2026-03-10 B Purchase
Loutskou, Steve

Director of Issuer, Senior Officer of Issuer

Executive Director
88,500
0.10
CA$8,850 		88,500 0.10 CA$8,850
2025-12-11 2025-12-10 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
150,000 +9.0%
0.11
CA$16,500 		150,000 +9.0% 0.11 CA$16,500
2025-12-11 2025-12-10 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
50,000
0.11
CA$5,500 		50,000 0.11 CA$5,500
2025-12-11 2025-12-10 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
75,000 +4.9%
0.11
CA$8,250 		75,000 +4.9% 0.11 CA$8,250
2025-12-11 2025-12-10 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
378,893 +32.7%
0.11
CA$41,678 		378,893 +32.7% 0.11 CA$41,678
2025-12-11 2025-12-10 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
200,000 +20.8%
0.11
CA$22,000 		200,000 +20.8% 0.11 CA$22,000
2025-12-11 2025-12-10 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
24,911 +2.7%
0.11
CA$2,740 		24,911 +2.7% 0.11 CA$2,740
2025-12-11 2025-12-09 B Purchase
Harrycharran, Khavita

Director of Issuer

Non-Executive Director
50,000 +5.6%
0.12
CA$6,000 		50,000 +5.6% 0.12 CA$6,000
Explore more

More insider trading research around Restart Life Sciences Corp

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America